Displaying 551-600 of 723 result(s).
Recent Articles
- Important Updates for Investors in PACS Group, Inc. Securities
- Diamyd Medical Unveils Promising Prospects for Diamyd® Treatment
- Commerzbank's Weidmann Discusses Challenges in UniCredit Merger
- Understanding Financial Tightening and Its Market Impact
- Economic Indicators and Their Impact on Market Trends Ahead
- Understanding the Growth Prospects of JPMorgan and Citigroup
- Velcan Holdings Launches New Buyback Program for Investors
- Celebrating Exceptional Talent: 2024 PenCraft Winners Revealed
- Record High Trade Between China and Russia Yields Insights
- Exploring Greenland's Untapped Mineral Wealth for Future Growth
- ENGWE Mapfour: Revolutionizing Urban Commuting Experience
- Porsche Faces Challenges as 2024 China Sales Plummet
- Jeff Wu Takes the Helm of Citigroup's Sales in China
- GSK's Strategic Acquisition of IDRx Enhances Cancer Portfolio
- Understanding the Current Economic Landscape and Stagflation
- Understanding S&P 500 Earnings Perspectives for 2025
- Market Trends Indicate Possible Bear Trap Formation Ahead
- Market Insights: Navigating Challenges Ahead for Investors
- Telix Pharmaceuticals Reports Record Q4 Earnings for 2024
- Eagle Eye Solutions Group Achieves Robust SaaS Expansion
- Orange County Bancorp's Strategic Moves Amid Market Challenges
- EnergyPathways Takes Significant Step for Marram Project
- Huawei Launches Revolutionary Foldable Devices in Dubai
- Crystal Amber Fund Boosts Stake in Morphic Medical Shares
- Georgia Capital Addresses Speculation on Political Allegations
- Eastern Pacific Shipping Partners with SulNOx for Eco-Friendly Fuel
- Pollen Street Group Welcomes Crispin Goldsmith as CFO
- IntelliAM AI Transitions Leadership with Chairman Change
- Eagle Eye Solutions Partners with Leading Software Vendor
- Pantheon Infrastructure's Landmark $16.4 Billion Calpine Sale
- US Analysis Reveals China's Shipbuilding Industry Dominance
- ICG Enterprise Trust Conducts Share Buyback to Enhance Value
- Telix Pharmaceuticals Reports Strong Financial Performance in Q4
- Datopotamab Deruxtecan: A New Hope for Lung Cancer Patients
- Kosmos Energy Announces Earnings Call for Q4 Results 2024
- Saba Capital Advocates for Change in Diverse U.K. Trusts
- Pricer and Focal Systems Team Up for Retail Digital Revolution
- ARMswap Unveils Groundbreaking DeFi Platform for Users
- CoreWeave Expands AI Footprint with New Data Centers in UK
- Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care
- Himax Technologies Outlines Upcoming Financial Results Call
- New Leadership at Arverne Group: Thierry Trouyet Appointed
- Huawei Launches Cutting-Edge Foldable Devices at Event
- Lufthansa's Strategic Stake in ITA Promises Significant Gains
- McPhy Energy Adjusts 2024 Revenue Outlook to 11 Million Euros
- Innovative Movement Restoration at J.P. Morgan Conference
- Tesla Adjusts Prices for Model 3 and Model Y in Canada
- Potential ECB Rate Adjustments: A Balanced Approach Ahead
- Bitcoin Continues Decline Amid Federal Reserve Concerns
- Gore's New Lower Profile VBX Stent Graft Enhances Patient Care